Feline Calicivirus Virulent Systemic Disease: Clinical Epidemiology, Analysis of Viral Isolates and In Vitro Efficacy of Novel Antivirals in Australian Outbreaks

Feline calicivirus (FCV) causes upper respiratory tract disease (URTD) and sporadic outbreaks of virulent systemic disease (FCV-VSD). The basis for the increased pathogenicity of FCV-VSD viruses is incompletely understood, and antivirals for FCV-VSD have yet to be developed. We investigated the clinicoepidemiology and viral features of three FCV-VSD outbreaks in Australia and evaluated the in vitro efficacy of nitazoxanide (NTZ), 2′-C-methylcytidine (2CMC) and NITD-008 against FCV-VSD viruses. Overall mortality among 23 cases of FCV-VSD was 39%. Metagenomic sequencing identified five genetically distinct FCV lineages within the three outbreaks, all seemingly evolving in situ in Australia. Notably, no mutations that clearly distinguished FCV-URTD from FCV-VSD phenotypes were identified. One FCV-URTD strain likely originated from a recombination event. Analysis of seven amino-acid residues from the hypervariable E region of the capsid in the cultured viruses did not support the contention that properties of these residues can reliably differentiate between the two pathotypes. On plaque reduction assays, dose–response inhibition of FCV-VSD was obtained with all antivirals at low micromolar concentrations; NTZ EC50, 0.4–0.6 µM, TI = 21; 2CMC EC50, 2.7–5.3 µM, TI > 18; NITD-008, 0.5 to 0.9 µM, TI > 111. Investigation of these antivirals for the treatment of FCV-VSD is warranted.

[1]  S. Dawson,et al.  Feline calicivirus. , 2022, Veterinary research.

[2]  P. O’Neill,et al.  Synthesis, antiviral activity, preliminary pharmacokinetics and structural parameters of thiazolide amine salts. , 2021, Future medicinal chemistry.

[3]  Yongkun Zhao,et al.  Nitazoxanide protects cats from feline calicivirus infection and acts synergistically with mizoribine in vitro , 2020, Antiviral Research.

[4]  K. Bányai,et al.  Identification of feline calicivirus in cats with enteritis. , 2020, Transboundary and emerging diseases.

[5]  H. Poulet,et al.  Multiple Correspondence Analysis on Amino Acid Properties within the Variable Region of the Capsid Protein Shows Differences between Classical and Virulent Systemic Feline Calicivirus Strains , 2019, Viruses.

[6]  V. Martella,et al.  Feline calicivirus infection in cats with virulent systemic disease, Italy. , 2019, Research in veterinary science.

[7]  J. Mackenzie,et al.  The Adenosine Analogue NITD008 has Potent Antiviral Activity against Human and Animal Caliciviruses , 2019, Viruses.

[8]  Alice G. Russo,et al.  Potential Therapeutic Agents for Feline Calicivirus Infection , 2018, Viruses.

[9]  R. Hofmann-Lehmann,et al.  Molecular characterization and virus neutralization patterns of severe, non-epizootic forms of feline calicivirus infections resembling virulent systemic disease in cats in Switzerland and in Liechtenstein. , 2016, Veterinary microbiology.

[10]  J. Deschamps,et al.  Nosocomial feline calicivirus-associated virulent systemic disease in a veterinary emergency and critical care unit in France , 2015, JFMS open reports.

[11]  Kunihiko Sadakane,et al.  MEGAHIT: an ultra-fast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graph , 2014, Bioinform..

[12]  K. Bok,et al.  Genetic characterization of feline calicivirus strains associated with varying disease manifestations during an outbreak season in Missouri (1995–1996) , 2014, Virus Genes.

[13]  A. Kipar,et al.  Virulent feline calicivirus disease in a shelter in italy: A case description , 2013, Research in Veterinary Science.

[14]  K. Katoh,et al.  MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability , 2013, Molecular biology and evolution.

[15]  J. Neyts,et al.  Inhibition of norovirus replication by the nucleoside analogue 2'-C-methylcytidine. , 2012, Biochemical and biophysical research communications.

[16]  R. Klopfleisch,et al.  Feline calicivirus-associated virulent systemic disease: not necessarily a local epizootic problem , 2011, The Veterinary Record.

[17]  O. Gascuel,et al.  New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. , 2010, Systematic biology.

[18]  P. Niyomrattanakit,et al.  An adenosine nucleoside inhibitor of dengue virus , 2009, Proceedings of the National Academy of Sciences.

[19]  D. Jas,et al.  A Nosocomial Outbreak of Feline Calicivirus Associated Virulent Systemic Disease in France , 2009, Journal of feline medicine and surgery.

[20]  Kyeong-Ok Chang,et al.  Molecular virology of feline calicivirus. , 2008, The Veterinary clinics of North America. Small animal practice.

[21]  A. Sheh,et al.  Feline caliciviruses (FCVs) isolated from cats with virulent systemic disease possess in vitro phenotypes distinct from those of other FCV isolates. , 2007, The Journal of general virology.

[22]  S. Dawson,et al.  Evolutionary Mechanisms of Persistence and Diversification of a Calicivirus within Endemically Infected Natural Host Populations , 2006, Journal of Virology.

[23]  S. Dawson,et al.  Long-term analysis of feline calicivirus prevalence and viral shedding patterns in naturally infected colonies of domestic cats , 2006, Veterinary Microbiology.

[24]  J. Rossignol.  Nitazoxanide in the treatment of acquired immune deficiency syndrome‐related cryptosporidiosis: results of the United States compassionate use program in 365 patients , 2006, Alimentary pharmacology & therapeutics.

[25]  S. Dawson,et al.  Lethal outbreak of disease associated with feline calicivirus infection in cats , 2006, Veterinary Record.

[26]  N. Pedersen,et al.  Virulent systemic feline calicivirus infection: Local cytokine modulation and contribution of viral mutants , 2006, Journal of feline medicine and surgery.

[27]  C. K. Grant,et al.  Pathologic, Immunohistochemical, and Electron Microscopic Findings in Naturally Occurring Virulent Systemic Feline Calicivirus Infection in Cats , 2004, Veterinary pathology.

[28]  K. Green,et al.  Mutagenesis of Tyrosine 24 in the VPg Protein Is Lethal for Feline Calicivirus , 2004, Journal of Virology.

[29]  D. Hussar.  New drugs of 2003. , 2004, Journal of the American Pharmacists Association : JAPhA.

[30]  N. Pedersen,et al.  An outbreak of virulent systemic feline calicivirus disease. , 2004, Journal of the American Veterinary Medical Association.

[31]  N. Pedersen,et al.  An epizootic of highly virulent feline calicivirus disease in a hospital setting in New England , 2003, Journal of feline medicine and surgery.

[32]  J. Gookin,et al.  Experimental infection of cats with Tritrichomonas foetus. , 2001, American journal of veterinary research.

[33]  N. Pedersen,et al.  An isolated epizootic of hemorrhagic-like fever in cats caused by a novel and highly virulent strain of feline calicivirus , 2000, Veterinary Microbiology.

[34]  K. Lole,et al.  Full-Length Human Immunodeficiency Virus Type 1 Genomes from Subtype C-Infected Seroconverters in India, with Evidence of Intersubtype Recombination , 1999, Journal of Virology.

[35]  I. Brierley,et al.  Identification of a protein linked to the genomic and subgenomic mRNAs of feline calicivirus and its role in translation. , 1997, The Journal of general virology.

[36]  J. Neill,et al.  Further characterization of the virus-specific RNAs in feline calicivirus infected cells , 1988, Virus Research.

[37]  T. Ellis.  Jaundice in a Siamese cat with in utero feline calicivirus infection. , 1981, Australian veterinary journal.

[38]  M. Fretz,et al.  A protein, VPg, covalently linked to 36S calicivirus RNA. , 1980, The Journal of general virology.

[39]  J. Bigger,et al.  NEW DRUGS. , 1979, Canadian Medical Association journal.

[40]  M. Sabine,et al.  Paw and mouth disease in a cat. , 1972, Australian veterinary journal.

[41]  D. Love,et al.  Sudden death in kittens associated with a feline picornavirus. , 1972, Australian veterinary journal.